1-9 of 9
Andrea Kew
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall and Progression Free Survival from the Mcrn-003/Myx.1 Trial: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma

Christopher P Venner, MD, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J White, MD, Andrew Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Marc Lalancette, MD FRCP, Martha L Louzada, MDMSc, Andrea Kew, MDFRCP(C), Arleigh McCurdy, MD, Tony Reiman, MD, Max Sherry, Gail T. McDonald, Bethany Elaine Monteith, MD, Engin Gul, BS, MBA, Bingshu E. Chen, Annette E. Hay
Journal: Blood
Blood (2019) 134 (Supplement_1): 1871.
https://doi.org/10.1182/blood-2019-122637
Published: 2019
Journal Articles

MCRN ¯ 003/MYX · 1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies

Christopher P. Venner, MD FRCPC, Richard Leblanc, MDFRCPC, Irwindeep Sandhu, MDFRCPC, Darrell J. White, MD, Andrew R Belch, MD, Donna E Reece, MD, Christine I Chen, MD, Sean Dolan, MD, Andrea Kew, MDFRCP(C), Marc Lalancette, MD FRCP, Martha L Louzada, MD, Arleigh McCurdy, MD BSc, Gail T. McDonald, Tony Reiman, MD, Laura Rodriguez, Lois E. Shepherd, Engin Gul, BSc, Bingshu E. Chen, Annette E Hay
Journal: Blood
Blood (2018) 132 (Supplement 1): 1984.
https://doi.org/10.1182/blood-2018-99-117824
Published: 2018
Journal Articles

Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Signy Chow, MD FRCP(C), Donna Reece, MD FRCP(C), Jonathan J. Keats, PhD, P. Leif Bergsagel, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Giovanni Piza Rodriguez, MD, Michael Sebag, MD PhD, Darrell J White, MD, Kevin Song, MD FRCP(C), Terrance Comeau, MD, Christopher P. Venner, MD, Christine I Chen, MD FRCP(C), Jean Roy, MD, Martha L Louzada, MD, Julie Stakiw, MD FRCP(C), Andrea Kew, MDFRCP(C), Vishal Kukreti, MD FRCP(C), Anca Prica, MD FRCP(C), Rodger Tiedemann, MBChB, PhD, Mariela Aura Pantoja, PhD MSc, Harminder Kaur Paul, MSc, Trevor J. Pugh, PhD, Suzanne Trudel, MD FRCP(C)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3057.
https://doi.org/10.1182/blood.V130.Suppl_1.3057.3057
Published: 2017
Journal Articles

Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Single Center Experience

Amarilis Figueiredo, MD, Harold Atkins, MDFRCPC, Natasha Kekre, MDMPH, FRCPC, Andrea Kew, MD, Arleigh McCurdy, MD
Journal: Blood
Blood (2016) 128 (22): 5874.
https://doi.org/10.1182/blood.V128.22.5874.5874
Published: 2016
Journal Articles

A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Amarilis Figueiredo, MD, Harold Atkins, MD FRCPC, Ranjeeta Mallick, PhD, Natasha Kekre, MD MPH, FRCPC, Andrea Kew, MD, Arleigh McCurdy, MD
Journal: Blood
Blood (2016) 128 (22): 4519.
https://doi.org/10.1182/blood.V128.22.4519.4519
Published: 2016
Journal Articles

Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study

Ambica Parmar, MD, Heather A Leitch, MD PhD, Richard A. Wells, MD DPhil, Thomas J. Nevill, MD FRCPC, Nancy Y Zhu, MDFRCPC, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Eve St-Hilaire, MD, Rajat Kumar, MD, Michelle Geddes, MD FRCPC, John Storring, MD, Andrea Kew, MD, April Shamy, MDM, Mohamed Elemary, MD MSc,PhD, Martha Lenis, Alex Mamedov, Rena Buckstein, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 1701.
https://doi.org/10.1182/blood.V126.23.1701.1701
Published: 2015
Journal Articles

Acute Promyelocytic Leukemia In Canada: Poor Outcomes In Older Patients Remain

Matthew D. Seftel, MRCP, FRCPC, MPH, Anna Serebrin, MD, Pascal Lambert, MSc, Julie Bergeron, MD, Janeve Everett, MD, Andrea Kew, MD, David Jones, Catherine Meloche, Kristjan Paulson, MD, FRCPC, Mitchell Sabloff, MSc, MD, CM ,FRCP(C), Ismial Sherif, John Storring, MD, Donna Turner, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1714.
https://doi.org/10.1182/blood.V122.21.1714.1714
Published: 2013
Journal Articles

Optimizing Patient Selection for Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia.

Jiri Pavlu, Andrea Kew, Beatrice Taylor-Roberts, Holger Auner, John Goldman, Jane Apperley, Richard Szydlo
Journal: Blood
Blood (2009) 114 (22): 3392.
https://doi.org/10.1182/blood.V114.22.3392.3392
Published: 2009
Journal Articles

Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.

Jiri Pavlu, Matthias Klammer, Ian Gabriel, Richard Szydlo, Eduardo Olavarria, Dragana Milojkovic, Andrea Kew, Katy Rezvani, Francesco Dazzi, David Marin, John Goldman, Jane Apperley
Journal: Blood
Blood (2008) 112 (11): 970.
https://doi.org/10.1182/blood.V112.11.970.970
Published: 2008